Radius Health (RDUS) Tops Q2 EPS by 9c

Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.67), $0.09 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $47.61 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• BofA expects Apple to top analyst expectations on July 30
• HSBC sees "some proper warnings signs emerging" in risk assets
• Burry covers half of his Oracle short bet